Page last updated: 2024-08-22

pimozide and Atherosclerotic Parkinsonism

pimozide has been researched along with Atherosclerotic Parkinsonism in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19907 (77.78)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Betz, AJ; Clark, K; Felsted, J; Font, L; Hockemeyer, J; Ishiwari, K; Korbey, S; Madson, L; Mirante, B; Muller, CE; Sager, TN; Salamone, JD1
Betz, A; Felsted, J; Ishiwari, K; Salamone, JD; Weber, S1
Annable, L; Chouinard, G1
Calne, DB; Claveria, LE; Haskayne, L; Lodge-Patch, IC; Pallis, CA; Petrie, A; Teychenne, PF1
Martin, IC1
Marsden, CD; Parkes, JD; Tarsy, D1
Arthurs, B; Codère, F; Dresner, S; Flanders, M; Gauthier, S; Stone, L1
Fog, R; Pakkenberg, H1

Reviews

1 review(s) available for pimozide and Atherosclerotic Parkinsonism

ArticleYear
Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
    Frontiers in bioscience : a journal and virtual library, 2008, May-01, Volume: 13

    Topics: Adenosine A2 Receptor Antagonists; Catalepsy; Humans; Jaw Diseases; Locomotion; Motor Activity; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Purines; Tremor; Xanthines

2008

Trials

6 trial(s) available for pimozide and Atherosclerotic Parkinsonism

ArticleYear
Pimozide in the treatment of newly admitted schizophrenic patients.
    Psychopharmacology, 1982, Volume: 76, Issue:1

    Topics: Acute Disease; Adult; Chlorpromazine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1982
Tardive dyskinesia treated with pimozide.
    Journal of the neurological sciences, 1975, Volume: 24, Issue:4

    Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Consciousness Disorders; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Perphenazine; Phenothiazines; Pimozide; Prochlorperazine; Promazine; Promethazine; Schizophrenia; Thioridazine

1975
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
    Acta psychiatrica Scandinavica, 1975, Volume: 51, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Schizophrenia; Thioridazine; Trifluoperazine; Trifluperidol

1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:4

    Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine

1975
The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 150

    Topics: Adolescent; Adult; Aged; Behavior; Female; Flupenthixol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide; Prolactin; Schizophrenia; Schizophrenic Psychology; Thioxanthenes

1987
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Archives of neurology, 1974, Volume: 31, Issue:5

    Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mouth Diseases; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Remission, Spontaneous; Salivary Gland Diseases; Tetrabenazine; Time Factors

1974

Other Studies

2 other study(ies) available for pimozide and Atherosclerotic Parkinsonism

ArticleYear
Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:2

    Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Jaw; Male; Movement; Parkinson Disease, Secondary; Pimozide; Rats; Rats, Sprague-Dawley; Tremor

2005
Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1987, Volume: 22, Issue:1

    Topics: Baclofen; Blepharoptosis; Blepharospasm; Botulinum Toxins; Drug Evaluation; Eyelid Diseases; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide

1987